BR112016029749A8 - composição para perda de peso, composição que compreende cinamaldeído e zinco, seus usos, e método para fabricação de umm produto alimentício - Google Patents
composição para perda de peso, composição que compreende cinamaldeído e zinco, seus usos, e método para fabricação de umm produto alimentícioInfo
- Publication number
- BR112016029749A8 BR112016029749A8 BR112016029749A BR112016029749A BR112016029749A8 BR 112016029749 A8 BR112016029749 A8 BR 112016029749A8 BR 112016029749 A BR112016029749 A BR 112016029749A BR 112016029749 A BR112016029749 A BR 112016029749A BR 112016029749 A8 BR112016029749 A8 BR 112016029749A8
- Authority
- BR
- Brazil
- Prior art keywords
- cinnamaldehyde
- composition
- zinc
- weight
- food product
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 9
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 title abstract 8
- 229940117916 cinnamic aldehyde Drugs 0.000 title abstract 8
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title abstract 4
- 239000011701 zinc Substances 0.000 title abstract 4
- 229910052725 zinc Inorganic materials 0.000 title abstract 4
- 235000013305 food Nutrition 0.000 title abstract 2
- 230000004580 weight loss Effects 0.000 title abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 206010033307 Overweight Diseases 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 230000003931 cognitive performance Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 230000015654 memory Effects 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000035807 sensation Effects 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 210000002820 sympathetic nervous system Anatomy 0.000 abstract 1
- 230000037221 weight management Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
omposições que compreendem cinamaldeído e zinco e métodos de uso de tais composições. a presente invenção refere-se a composições que compreendem uma quantidade de cinamaldeído que é tolerável para ingestão oral, evitando assim uma sensação desagradável na boca, e que é também tolerável no trato gastrointestinal. a quantidade de cinamaldeído é suplementada por zinco, e a combinação é eficaz para aumentar ao menos um dentre gasto energético, atividade do sistema nervoso simpático, ou oxidação de gordura, em relação a uma composição isenta de cinamaldeído e zinco mas, de outro modo, idêntica. a composição compreendendo a combinação de cinamaldeído e zinco pode ser usada em um método para ajudar no gerenciamento de peso ou para promover a perda de peso, em um método para evitar obesidade ou excesso de peso, e em um método para tratar obesidade ou excesso de peso. em uma modalidade, a composição compreendendo cinamaldeído é administrada a um ser humano. a composição compreendendo cinamaldeído pode ser um medicamento, um produto alimentício ou um suplemento. a composição pode melhorar um ou mais dentre sensibilidade à insulina, tolerância à glicose, desempenho cognitivo, cognição, humor ou memória.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462026157P | 2014-07-18 | 2014-07-18 | |
| US62/026,157 | 2014-07-18 | ||
| PCT/EP2015/062696 WO2016008642A2 (en) | 2014-07-18 | 2015-06-08 | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112016029749A2 BR112016029749A2 (pt) | 2017-08-22 |
| BR112016029749A8 true BR112016029749A8 (pt) | 2021-03-16 |
| BR112016029749B1 BR112016029749B1 (pt) | 2021-10-26 |
Family
ID=53366030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016029749-0A BR112016029749B1 (pt) | 2014-07-18 | 2015-06-08 | Uso de cinamaldeído e de composto compreendendo zinco na preparação de composições alimentícias |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10092028B2 (pt) |
| EP (2) | EP3756475A1 (pt) |
| JP (2) | JP2017526643A (pt) |
| CN (1) | CN106470691B (pt) |
| AU (1) | AU2015291442B2 (pt) |
| BR (1) | BR112016029749B1 (pt) |
| CA (2) | CA3132696C (pt) |
| ES (1) | ES2822524T3 (pt) |
| WO (1) | WO2016008642A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3119385B2 (en) * | 2014-03-20 | 2020-11-11 | Société des Produits Nestlé S.A. | Composition comprising cinnamaldehyde and zinc to improve swallowing |
| AU2016269605B2 (en) * | 2015-06-05 | 2021-03-04 | Société des Produits Nestlé S.A. | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions |
| US20180125795A1 (en) * | 2017-01-03 | 2018-05-10 | Thermolife International, Llc | Cinnamaldehyde compositions and methods |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4469674A (en) * | 1981-09-03 | 1984-09-04 | Richardson-Vicks Inc. | Stable oral compositions containing zinc and fluoride compounds |
| AU1094301A (en) * | 1999-10-19 | 2001-04-30 | Nutrasweet Company, The | Personal care products using n-(n-(3,3-dimethylbutyl)-1-alpha-aspartyl)-l-phenylalanine methyl ester |
| DE202004017113U1 (de) * | 2004-11-05 | 2004-12-30 | Salus-Haus Gmbh & Co. Kg | Momordica charantia-Zimt-Zubereitung |
| KR20120122597A (ko) * | 2011-04-29 | 2012-11-07 | 영남대학교 산학협력단 | 계피 추출물을 유효성분으로 함유하는 대사증후군의 예방 및 치료용 조성물 |
| US20160339058A1 (en) * | 2014-03-20 | 2016-11-24 | Nestec S.A. | Methods and compositions for using cinnamaldehyde and zinc for weight management |
-
2015
- 2015-06-08 EP EP20184577.3A patent/EP3756475A1/en active Pending
- 2015-06-08 EP EP15727655.1A patent/EP3169170B1/en active Active
- 2015-06-08 AU AU2015291442A patent/AU2015291442B2/en active Active
- 2015-06-08 CN CN201580034856.3A patent/CN106470691B/zh active Active
- 2015-06-08 JP JP2017501660A patent/JP2017526643A/ja active Pending
- 2015-06-08 WO PCT/EP2015/062696 patent/WO2016008642A2/en active Application Filing
- 2015-06-08 BR BR112016029749-0A patent/BR112016029749B1/pt active IP Right Grant
- 2015-06-08 US US15/327,108 patent/US10092028B2/en active Active
- 2015-06-08 ES ES15727655T patent/ES2822524T3/es active Active
- 2015-06-08 CA CA3132696A patent/CA3132696C/en active Active
- 2015-06-08 CA CA2951090A patent/CA2951090A1/en active Pending
-
2019
- 2019-04-25 JP JP2019084115A patent/JP6869286B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3132696C (en) | 2023-10-10 |
| US20170164648A1 (en) | 2017-06-15 |
| CA2951090A1 (en) | 2016-01-21 |
| EP3169170A2 (en) | 2017-05-24 |
| JP6869286B2 (ja) | 2021-05-12 |
| US10092028B2 (en) | 2018-10-09 |
| JP2017526643A (ja) | 2017-09-14 |
| BR112016029749B1 (pt) | 2021-10-26 |
| CN106470691B (zh) | 2020-04-03 |
| EP3169170B1 (en) | 2020-07-08 |
| CN106470691A (zh) | 2017-03-01 |
| EP3756475A1 (en) | 2020-12-30 |
| WO2016008642A2 (en) | 2016-01-21 |
| AU2015291442B2 (en) | 2019-04-11 |
| CA3132696A1 (en) | 2016-01-21 |
| ES2822524T3 (es) | 2021-05-04 |
| JP2019142940A (ja) | 2019-08-29 |
| AU2015291442A1 (en) | 2016-12-08 |
| BR112016029749A2 (pt) | 2017-08-22 |
| WO2016008642A3 (en) | 2016-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018002394A2 (es) | Método para la inhibición de la absorción de lípidos y/o la promoción de excreción de lípidos usando d-psicosa | |
| BR112016011195A2 (pt) | Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico | |
| AR097178A1 (es) | Diagnóstico y terapias anticáncer que comprenden células madre cancerosas | |
| BR112013010556A2 (pt) | métodos e composições adequadas para a promoção de uma pele saudável | |
| BR112014008511A2 (pt) | composições nutricionais com fitonutrientes | |
| BR112016029713A2 (pt) | métodos para o tratamento de sobrepeso ou obesidade | |
| BR112015022514A2 (pt) | composições que compreendem selênio e uso das mesmas para o tratamento e prevenção de doença ou condições associadas à disfunção mitocondrial | |
| BR112017006416A2 (pt) | composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico | |
| MX2016009231A (es) | Administracion de tasimelteon en condiciones de ayuno. | |
| BR112018003745A2 (pt) | composições que compreendem um composto de urolitina | |
| BR112015017251A8 (pt) | composições farmacêuticas compreendendo doadores de nitroxil, misturas e usos das referidas composições farmacêuticas | |
| TR201821157T4 (tr) | İbandroni̇k asi̇t veya bunun farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzu ve d vi̇tami̇ni̇ i̇çeren oral uygulamaya yöneli̇k kati bi̇leşi̇m. | |
| BR112018000242A2 (pt) | composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico | |
| BR112018000236A2 (pt) | composições nutricionais e métodos para a promoção do desenvolvimento cognitivo | |
| EP3318251A3 (en) | Composition for preventing or treating obesity or lipid-related metabolic disease | |
| BR112016029749A8 (pt) | composição para perda de peso, composição que compreende cinamaldeído e zinco, seus usos, e método para fabricação de umm produto alimentício | |
| BR112014027738A2 (pt) | ácido graxo de talóleo que é modificado por saponificação para uso, suplemento alimentar, e composto alimentar | |
| BR112019010057A2 (pt) | composição, método para suprimir a ingestão de comida, sequência de shrna, método de inibição da síntese de ácidos graxos | |
| BR112017026834A2 (pt) | composição compreendendo vitaminas b e vitaminas c e seu uso | |
| BR112016017765A8 (pt) | composição compreendendo cinamaldeído e zinco, seu uso, e método para produzir um produto alimentício para perda de peso | |
| BR112015031416A2 (pt) | métodos para a promoção do desenvolvimento e/ou da saúde neuronal compreendendo a administração de uma combinação de ácido docosa-hexaenoico e ácido alfa-lipoico | |
| BR112016012233A8 (pt) | composições compreendendo cinamaldeído, e seus usos | |
| BR112017023493A2 (pt) | composições que compreendem cinamaldeído e zinco e métodos de uso de tais composições | |
| BR112017008747A2 (pt) | composições nutricionais contendo um prebiótico e lactoferrina e seus usos | |
| BR112018067967A2 (pt) | tratamento de pacientes com hipercolesterolemia familiar homozigótica por meio de terapia hipolipemiante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH) |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/06/2015, OBSERVADAS AS CONDICOES LEGAIS. |